Oxybutynin Chloride Tablet
Product Images NDC 10702-201

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 10702-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kvk-tech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Figure 1 Structure)

Chemical structure diagram of Oxybutynin Chloride showing its molecular framework, including ring systems, triple bonds, and functional groups, labeled with associated atoms and bonds.*

FDA Label Image

1000s Label (Figure 10 1000s Label)

Label for Oxybutynin Chloride Tablets, USP 5 mg oral tablets, containing 1000 tablets. The label includes dosage instructions, storage conditions, a warning to keep out of reach of children, and manufacturing details by KVK-Tech, Inc., Newtown, PA.*

FDA Label Image

Table 1 (Figure 2 Table1)

A data table comparing pharmacokinetic parameters for R-Oxybutynin and S-Oxybutynin including Cmax (ng/mL), Tmax (hours), AUCt (ng·h/mL), and AUCinf (ng·h/mL) with corresponding values and standard deviations shown in parentheses.*

FDA Label Image

Figure 1 (Figure 3 Figure1)

A line graph showing mean plasma R-oxybutynin concentration (ng/mL) over 24 hours for Oxybutynin 5 mg taken three times daily (TID). The x-axis represents time in hours, and the y-axis shows concentration levels, with error bars indicating variability at each time point.*

FDA Label Image

Table 2 (Figure 4 Table2)

A data table presenting pharmacokinetic parameters of Oxybutynin Chloride metabolites R-Oxybutynin, S-Oxybutynin, R-Desethyloxybutynin, and S-Desethyloxybutynin, including Cmax (ng/mL), Tmax (hours), and AUC (ng·hr/mL), with mean values and standard deviations for each metabolite.*

FDA Label Image

Figure 2 (Figure 5 Figure2)

A line graph depicting mean R-Oxybutynin plasma concentration (ng/mL) over time (hours). The y-axis represents plasma concentration ranging from 0 to 10 ng/mL, and the x-axis represents time from 0 to 12 hours. Data points show plasma concentration peaking shortly after administration and gradually decreasing over 12 hours, with error bars indicating variability.*

FDA Label Image

Table 3 (Figure 6 Table3)

Data table presenting adverse events associated with Oxybutynin Chloride (5-20 mg/day) across various body systems. The table lists specific adverse events like urinary tract infection, insomnia, dizziness, blurred vision, dry mouth, and urinary hesitation, with corresponding incidence percentages in patients (n=199).*

FDA Label Image

Kvk Logo (Figure 7 Company Logo)

FDA Label Image

100s Label (Figure 8 100s Label)

Oxybutynin Chloride Tablets, USP 5 mg label from KVK-Tech, Inc., for oral use. The label indicates each tablet contains 5 mg of oxybutynin chloride. Packaging includes dosage instructions, storage conditions, and a 100-tablet count with official NDC 10702-201-01 barcoded. The product is prescription only and manufactured in Newtown, PA, USA.*

FDA Label Image

500s Label (Figure 9 500s Label)

Oxybutynin Chloride Tablets, USP 5 mg oral tablets in a 500 count package. The label shows the dosage strength of 5 mg per tablet and includes storage instructions and usage directions. The labeler is KVK-Tech, Inc., with product NDC 10702-201. The package is marked for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.